Publication | Closed Access
Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy fornon-small-cell lung cancer
43
Citations
17
References
2003
Year
OncologyMedicineMetronomic TherapyPhase Ii StudyBronchial NeoplasmPharmacotherapyCancer TreatmentPharmacologyRadiation OncologyLung Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1